Multiplexed electrical detection of cancer markers with nanowire sensor arrays

Nature Biotechnology

Volumn 23, Issue 10, 2005, Pages 1294-1301

  Zheng, Gengfeng ^a   Patolsky, Fernando ^a   Cui, Yi ^a   Wang, Wayne U ^a,b   Lieber, Charles M ^a,c  

^a HARVARD UNIVERSITY   (United States)

^b HARVARD UNIVERSITY   (United States)

^c HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; ARRAYS; BIOSENSORS; FIELD EFFECT SEMICONDUCTOR DEVICES; NANOSTRUCTURED MATERIALS; PROTEINS; SILICON; TUMORS;

CANCER MARKERS; ELECTRICAL DETECTION; SILICON-NANOWIRE; SURFACE RECEPTORS;

BIOMARKERS;

ALPHA 1 ANTICHYMOTRYPSIN; CARCINOEMBRYONIC ANTIGEN; MUCIN 1; NANOPARTICLE; PROSTATE SPECIFIC ANTIGEN; SILICON; TELOMERASE; TUMOR MARKER;

ANTIGEN DETECTION; ARTICLE; CANCER CYTODIAGNOSIS; CELL LABELING; CONTROLLED STUDY; DEVICE; DIAGNOSTIC ACCURACY; DISEASE MARKER; ELECTRIC ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MICROARRAY; QUANTITATIVE ANALYSIS;

BIOSENSING TECHNIQUES; ELECTRIC WIRING; ELECTROCHEMISTRY; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; HUMANS; IMMUNOASSAY; MICROELECTRODES; NANOTECHNOLOGY; NEOPLASM PROTEINS; NEOPLASMS; PROTEIN ARRAY ANALYSIS; SIGNAL PROCESSING, COMPUTER-ASSISTED; TELOMERASE; TRANSDUCERS; TUMOR MARKERS, BIOLOGICAL;

EID: 27144513329     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt1138     Document Type: Article

References (49)

1. Sander, C. Genomic medicine and the future of health care. Science 287, 1977-1978 (2000).
2. Etzioni, R. et al. The case for early detection. Nat. Rev. Cancer 3, 243-252 (2003).
3. Srinivas, P.R., Kramer, B.S. & Srivastava, S. Trends in biomarker research for cancer detection. Lancet Oncol. 2, 698-704 (2001).
4. Wulfkuhle, J.D., Liotta, L.A. & Petricoin, E.F. Proteomic applications for the early detection of cancer. Nat. Rev. Cancer 3, 267-275 (2003).
5. Brawer, M.K. Prostate Specific Antigen (Marcel Dekker, New York, 2001).
6. Sidransky, D. Emerging molecular markers of cancer. Nat. Rev. Cancer 2, 210-219 (2002).
7. Abeloff, M.D., Armitage, J.O., Lichter, A.S. & Niederbuber, J.E. Clinical Oncology (Churchill Livingstone, New York, 2000).
8. Ward, A.M., Catto, J.W.F. & Hamdy, F.C. Prostate specific antigen: biology, biochemistry and available commercial assays. Ann. Clin. Biochem. 38, 633-651 (2001).
9. Campagnolo, C. et al. Real-Time, label-free monitoring of tumor antigen and serum antibody interactions. J. Biochem. Biophys. Methods 61, 283-298 (2004).
10. Chou, S.F., Hsu, W.L., Hwang, J.M. & Chen, C.Y. Development of an immunosensor for human ferritin, a nonspecific tumor marker, based on surface plasmon resonance. Biosens. Bioelectron. 19, 999-1005 (2004).
11. Alivisatos, P. The use of nanocrystals in biological detection. Nat. Biotechnol. 22, 47-52 (2004).
12. Gao, X., Cui, Y., Levenson, R.M., Chung, L.W.K. & Nie, S. In vivo targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 22, 969-976 (2004).
13. Soukka, T. et al. Supersensitive time-resolved immunofluorometric assay of free prostate-specific antigen with nanoparticle label technology. Clin. Chem. 47, 1269-1278 (2001).
14. Nam, J.M., Thaxton, C.S. & Mirkin, C.A. Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science 301, 1884-1886 (2003).
15. Wu, G. et al. Bioassay of prostate-specific antigen (PSA) using microcantilevers. Nat. Biotechnol. 19, 856-860 (2001).
16. Chen, R.J. et al. Noncovalent functionalization of carbon nanotubes for highly specific electronic biosensors. Proc. Natl. Acad. Sci. USA 100, 4984-4989 (2003).
17. Chen, R.J. et al. An investigation of the mechanisms of electronic sensing of protein adsorption on carbon nanotube devices. J. Am. Chem. Soc. 126, 1563-1568 (2004).
18. Cui, Y., Wei, Q.Q., Park, H.K. & Lieber, C.M. Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species. Science 293, 1289-1292 (2001).
19. Ferrari, M. Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer 5, 161-171 (2005).
20. MacBeath, G. & Schreiber, S.L. Printing proteins as microarrays for high-throughput function determination. Science 289, 1760-1763 (2000).
21. Arenkov, P. et al. Protein microchips: use for immunoassay and enzymatic reactions. Anal. Biochem. 278, 123-131 (2000).
22. Patolsky, F. et al. Electrical detection of single viruses. Proc. Natl. Acad. Sci. USA 101, 14017-14022 (2004).
23. Wang, W.U., Chen, C., Lin, K.H., Fang, Y. & Lieber, C.M. Label-free detection of small-molecule-protein interactions by using nanowire nanosensors. Proc. Natl. Acad. Sci. USA 102, 3208-3212 (2005).
24. Armbruster, D.A. Prostate-specific antigen: biochemistry, analytical methods and clinical application. Clin. Chem. 39, 181-195 (1993).
25. Pomerantz, M., Segmuller, A., Netzer, L. & Sagiv, J. Coverage of Si substrates by self-assembling monolayers and multilayers as measured by IR, wettability and x-ray diffraction. Thin Solid Films 132, 153-162 (1985).
26. Heiney, P.A., Gruneberg, K., Fang, J.Y., Dulcey, C. & Shashidhar, R. Structure and growth of chromophore-functionalized (3-aminopropyl) triethoxysilane self-assembled on silicon. Langmuir 16, 2651-2657 (2000).
27. Sze, S.M. Physics of Semicondutor Devices (John Wiley & Sons, New York, 1981).
28. 1-antichymotrypsin. Clin. Chem. 37, 1618-1625 (1991).
29. 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res. 51, 222-226 (1991).
30. 1-antichymotrypsin improves the discrimination between prostate cancer and benign prostatic hyperplasia in men with a total PSA of 10 to 30 μg/L. Clin. Chem. 48, 1251-1256 (2002).
31. Moyzis, R.K. et al. A highly conserved repetitive DNA-sequence, (TTAGGG)N, present at the telomeres of human-chromosomes. Proc. Natl. Acad. Sci. USA 85, 6622-6626 (1988).
32. Morin, G.B. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59, 521-529 (1989).
33. O'Reilly, M., Teichmann, S.A. & Rhodes, D. Telomerases. Curr. Opin. Struct. Biol. 9, 56-65 (1999).
34. Rhyu, M.S. Telomeres, telomerase and immortality. J. Natl. Cancer Inst. 87, 884-894 (1995).
35. Shay, J.W. & Bacchetti, S. A survey of telomerase activity in human cancer. Eur. J. Cancer 33, 787-791 (1997).
36. Kim, N.W. et al. Specifc association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015 (1994).
37. Nugent, C.I. & Lundblad, V. The telomerase reverse transcriptase: components and regulation. Genes Dev. 12, 1073-1085 (1998).
38. Shippen-Lentz, D. & Blackburn, E.H. Functional evidence for an RNA template in telomerase. Science 247, 546-552 (1990).
39. Hirose, M. et al. A rapid, useful and quantitative method to measure telomerase activity by hybridization protection assay connected with a telomeric repeat amplification protocol. J. Cancer Res. Clin. Oncol. 123, 337-344 (1997).
40. Gelmini, S. et al. Rapid, quantitative nonisotopic assay for telomerase activity in human tumors. Clin. Chem. 44, 2133-2138 (1998).
41. Uehara, H., Nardone, G., Nazarenko, I. & Hohman, R.J. Detection of telomerase activity utilizing energy transfer primers: comparison with gel- and ELISA-based detection. Biotechniques 26, 552-558 (1999).
42. Szatmari, I., Tokes, S., Dunn, C.B., Bardos, T.J. & Aradi, J. Modified telomeric repeat amplification protocol: a quantitative radioactive assay for telomerase without using electrophoresis. Anal. Biochem. 282, 80-88 (2000).
43. Wege, H., Chui, M.S., Le, H.T., Tran, J.M. & Zern, M.A. SYBR Green real time telomeric repeat amplification protocol for the rapid quantification of telomerase activity. Nucleic Acids Res. 31 (No. 2 e3), 1-7 (2003).
44. Mitsuya, H., Yarchoan, R. & Broder, S. Molecular targets for AIDS therapy. Science 249, 1533-1544 (1990).
45. Miyashita, M., Shimada, T., Miyagawa, H. & Akamatsu, M. Surface plasmon resonance-based immunoassay for 17 beta-estradiol and its application to the measurement of estrogen receptor-binding activity. Anal. Bioanal. Chem. 381, 667-673 (2005).
46. Haes, A.J., Hall, W.P., Chang, L., Klein, W.L. & Van Duyne, R.P. A localized surface plasmon resonance biosensor: first steps toward an assay for Alzheimer's disease. Nano Lett. 4, 1029-1034 (2004).
47. Cui, Y., Zhong, Z., Wang, D., Wang, W.U. & Lieber, C.M. High performance silicon nanowire field effect transistors. Nano Lett. 3, 149-152 (2003).
48. Zheng, G., Lu, W., Jin, S. & Lieber, C.M. Synthesis and fabrication of high-performance n-type silicon nanowire transistors. Adv. Mater. 16, 1890-1893 (2004).
49. Wong, P.K., Chen, C.-Y., Wang, T.-H. & Ho, C.-M. Electrokinetic bioprocessor for concentrating cells and molecules. Anal. Chem. 76, 6908-6914 (2004).